Drugs / H. pylori vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02302170 | Dec 2004 → Sep 2006 | Helicobacter pylori infectious disease | Jiangsu Province Centers for Disease Control and Prevention | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | H. pylori vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02302170 ↗ |
| Modality | Vaccine | “oral recombinant Helicobacter pylori vaccine” NCT02302170 ↗ |
| Route | Oral | “a three-dose oral recombinant H pylori vaccine” PMID 26142048 ↗ Jun 2015 |